Wearable clinical monitoring technology

OPM: advanced optical sensing for real world care

Delivering reliable, inclusive physiological monitoring in real-world clinical conditions across diverse patient populations.

How OPM works

Opto Physiological Monitoring (OPM) is Carelight’s proprietary sensing technology, designed to capture high-quality physiological signals continuously and non-invasively. By combining optical sensing with advanced signal processing, OPM supports earlier insight, greater accuracy and more reliable long-term monitoring.

The problem

Optical sensing promises continuous, non-invasive monitoring, but current PPG-based devices fail in real-world use. Motion artefacts, skin tone bias and poor perfusion degrade signal quality, limiting accuracy and excluding patients when conditions move beyond settings.

Optical sensing technologies such as photoplethysmography (PPG) have been used in clinical settings for decades, yet their real-world performance remains constrained. Signal quality is highly sensitive to motion, perfusion changes and optical interference caused by skin tone variation. During the Covid-19 pandemic, these limitations became more visible.

Studies showed that conventional pulse oximeters can overestimate oxygen saturation in darker skin tones, increasing the risk of missed hypoxaemia and delayed clinical intervention.

At a technical level, this is driven by the way most PPG devices operate: using a two-dimensional, point-based optical measurement that interacts with only a small volume of tissue. This limits vessel engagement, amplifies noise and reduces reliability when conditions move beyond controlled environments.

Our solution

Carelight’s OPM applies a 3D, multispectral optical architecture that interrogates tissue volume rather than a single point. By modelling light transport through tissue types, it improves vessel interaction, resists motion interference and delivers reliable signals.

Carelight’s Opto Physiological Monitoring (OPM) technology takes a fundamentally different approach to optical sensing. Rather than relying on point measurements, OPM uses a three-dimensional, multispectral illumination design that interrogates a volume of tissue.

By applying radiative transport theory, OPM models how light of different wavelengths interacts with complex biological structures including blood, skin, muscle and connective tissue. This allows the system to capture higher-definition physiological signals while remaining robust to motion and variability between individuals.

The result is a more complete optical model that improves signal-to-noise performance, maintains consistency across skin tones and oxygenation levels, and enables reliable physiological monitoring in conditions where traditional PPG devices struggle.

The opportunity

With reliable optical sensing in real-world conditions, OPM unlocks broader clinical use. It supports inclusive monitoring across skin tones and activity levels, and creates the potential to reduce wired bedside equipment, transforming care across settings.

With the technical limitations of conventional optical sensing addressed, new clinical and commercial possibilities emerge. Reliable, inclusive signal capture enables optical monitoring to move beyond tightly controlled environments and into everyday clinical and care settings.

OPM opens the potential to reduce dependence on wired bedside equipment, particularly in high-dependency environments where clinicians are constrained by cables, probes and fixed machines. By supporting continuous, non-invasive monitoring across varied patient populations and activity levels, OPM can simplify workflows while improving patient comfort and access.

This creates opportunities not only in community and remote care, but also across hospital environments where flexible, high-quality sensing can change how monitoring is delivered.

Core innovations

To deliver reliable optical sensing in real-world conditions, OPM is built around five core innovations. Each addresses a specific technical limitation of conventional systems, working together to support consistent, high-quality physiological measurement across environments, patients and use cases.
[ 1.0 ]

3D optical system

OPM uses a three-dimensional, multispectral optical architecture to interrogate tissue volume, improving vessel interaction, signal quality and robustness beyond traditional point-based sensing.
[ 2.0 ]

Tissue-aware light modelling

OPM applies tissue-aware light modelling to maintain pulsatile signal quality and measurement accuracy across skin tones, wavelengths and physiological conditions.
[ 3.0 ]

AI-powered adaptive Illumination

Machine learning continuously fine-tunes light intensity and wavelength, optimising signal quality in real-time clinical conditions.
[ 4.0 ]

Motion-robust readings

PM maintains accurate heart rate measurement during movement by filtering motion artefacts and noise, delivering reliable readings during walking and running.
[ 5.0 ]

High-definition pulsatile wave

OPM preserves high-definition pulsatile signals during oxygen desaturation, enabling reliable multi-parameter physiological measurement in real-world and clinically challenging conditions.

Parameters available

Carelight’s first Weartech product will deliver hospital-level accuracy on multiple vital signs, validated against gold-standard methods.

[ AVAILABLE ]

Heart rate (HR)

Clinical accuracy → ±2 bpm
[ AVAILABLE ]

Heart rate variability (HRV)

Clinical accuracy → ±5 ms
[ AVAILABLE ]

Respiratory rate

Clinical accuracy → ±1 rpm
[ AVAILABLE ]

Oxygen saturation (SpO₂)

Clinical accuracy → ±2%
[ AVAILABLE ]

Perfusion index (PI)

Clinical accuracy → ±0.1%
[ AVAILABLE ]

Core temperature

Clinical accuracy → ±0.2°C

What’s onboard

The first generation of Weartech devices are powered by OPM and AI signal processing, capturing the fine features in the pulsatile signal to deliver hospital-level accuracy, even during movement and across every skin tone.

What’s next

OPM is just the start. The next wave of Weartech devices will integrate multi-modal sensing – OPM plus motion plus ECG – combined with AI interpretation to create richer cardiovascular insights, from rhythm irregularities to recovery monitoring and pushing wearable care beyond anything possible today.

What’s next for OPM

We’re expanding beyond today’s vital signs. From blood pressure to fluid status, OPM is advancing toward broader cardiovascular monitoring, opening the door to deeper insights, AI-powered predictions and stronger clinical decisions.

[ In Development ]

Hypertension

Expected timeline → Q3 2025

[ In Development ]

Cardiac biomarkers

Expected timeline → Q4 2025
[ RESEARCH ]

Cardiac output

Expected timeline → 2026
[ RESEARCH ]

Fluid status

Expected timeline → 2026
[ RESEARCH ]

Stroke risk

Expected timeline → TBC
[ RESEARCH ]

Sepsis

Expected timeline → TBC
[ RESEARCH ]

Peripheral arterial disease (PAD)

Expected timeline → TBC

[ Clinical applications ]

Flexible by design

Carelight’s OPM adapts to different Weartech formats, from patches to wrist and chest sensors – with AI ensuring the same clinical-grade accuracy wherever monitoring is needed.

[ Product (pre-submission) ]

Wrist-worn pulse oximetry

Lightweight wrist wear for long-term monitoring and everyday integration.

ParametersHR, RR, HRV, SpO₂, PI
Regulatory → FDA 510(k) planned Q3 2026
Launch → TBC

[ In development ]

Chest-worn cardiac monitoring

High fidelity cardiac monitoring and diagnostic applications.

ParametersHR, RR, HRV, SpO₂, PI; ECG, cardiac functions
Regulatory → FDA 510(k) planned Q1 2028

[ In development ]

Paediatric intensive care

Small, light and wire free multiparameter monitoring.

ParametersHR, RR, HRV, SpO₂, PI, BP; ECG, cardiac functions
Regulatory → FDA 510(k) planned Q1 2028

[ In development ]

Operating theatre monitoring

Providing an accessible solution to congested patient space.

ParametersHR, RR, HRV, SpO₂, PI; ECG, cardiac functions
Regulatory → FDA 510(k) planned Q1 2028

Seamless system integration

Designed for healthcare at scale: FHIR-compliant, EMR-ready, and secured with enterprise-grade protocols.

Platform specifications

Key technical parameters for engineers and integration teams evaluating OPM-powered Weartech devices for real-world deployment, with AI-driven performance built in.

OPM platform specifications

Sensor configuration

3D multi-wavelength array

Sampling rate

Up to 1000 Hz

Battery life

7+ days typical use

Operating temperature

5°C to 45°C

Connectivity

Bluetooth 5.2, Wi-Fi 6

Sensor configuration

3D multi-wavelength array

Sampling rate

Up to 1000 Hz

Battery life

7+ days typical use

Operating temperature

5°C to 45°C

Connectivity

Bluetooth 5.2, Wi-Fi 6